Rank #322 · Healthcare
Andreas Struengmann & family
Pharmaceuticals · Germany
Net worth$10.5B
Today−$22M
7 days−$238K
30 days−$454M
Net worth, last 30 days
Low $10.5BHigh $11.0B
Biography
Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.
The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.
The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.
In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.
Did you know
After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa.
Holdings
| Company | Ticker | Shares | Value |
|---|---|---|---|
| BioNTech Sponsored ADR | BNTX-US | 50,640,000 | $4.1B |
| Formycon AG | FYB-DE | 2,124,000 | $30M |
| Private assets & other | $6.3B | ||